CN113663059A - Anti-aging beauty injection and preparation method thereof - Google Patents

Anti-aging beauty injection and preparation method thereof Download PDF

Info

Publication number
CN113663059A
CN113663059A CN202111010494.8A CN202111010494A CN113663059A CN 113663059 A CN113663059 A CN 113663059A CN 202111010494 A CN202111010494 A CN 202111010494A CN 113663059 A CN113663059 A CN 113663059A
Authority
CN
China
Prior art keywords
parts
vitamin
injection
collagen
mixed solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN202111010494.8A
Other languages
Chinese (zh)
Inventor
王云峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou Gusu Xinyan Meili Medical Beauty Clinic Co ltd
Original Assignee
Suzhou Gusu Xinyan Meili Medical Beauty Clinic Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suzhou Gusu Xinyan Meili Medical Beauty Clinic Co ltd filed Critical Suzhou Gusu Xinyan Meili Medical Beauty Clinic Co ltd
Priority to CN202111010494.8A priority Critical patent/CN113663059A/en
Publication of CN113663059A publication Critical patent/CN113663059A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention discloses an anti-aging beauty injection and a preparation method thereof, relating to the technical field of medical beauty, and the anti-aging beauty injection comprises the following components in parts by weight: 18-25 parts of physiological saline, 19-29 parts of collagen, 23-32 parts of hyaluronic acid, 7-11 parts of poly-L-lactic acid, 5-6 parts of glutathione, 2-3 parts of mannitol and 1-3 parts of vitamin. The invention has the filling effect by adding collagen and hyaluronic acid, and can effectively solve the problem of short-time insufficient secretion of body fluid by adding physiological saline; the polylactic acid mainly has the functions of stimulating an organism to independently generate collagen, activating various enzymes by matching with glutathione, promoting the metabolism of sugar, fat and protein, improving the osmotic pressure of blood plasma by mannitol, improving the activity of cells by vitamins, stimulating the cells to absorb the injection from multiple aspects, and solving the problems that the injection position bulges and the cosmetic effect is poor due to the phenomena of aggregation, uneven absorption and poor absorption effect easily caused by the cosmetic injection in the prior art.

Description

Anti-aging beauty injection and preparation method thereof
Technical Field
The invention relates to the technical field of medical cosmetology, in particular to an anti-aging cosmetology injection and a preparation method thereof.
Background
The body is the original money of revolution, under the great environment of social competition and increasing pressure, more and more people exchange dreams and wealth through healthy bodies in young age, exchange healthy bodies through wealth in old age, and finally, the dreams of most people are realized by keeping young and healthy bodies. Certainly, with the progress of society and the development of science and technology, living material conditions obtained by people are better and better, and a plurality of advanced medical technology and cosmetic technology can realize the dream of delaying aging of people to a certain extent. With the rise and development of beauty industry, people's aesthetic concepts are gradually changed, and more people are no longer satisfied with changing their appearances by home care means such as external skin care products and oral beauty products, gradually contacting and trying to improve their appearance by medical beauty technology, and resisting aging. The anti-aging beauty injection is a common anti-aging injection mode.
The injection anti-aging means that a needle tube is used for injecting an injection beauty injection product to the depressed part of the face wrinkles, and the damaged skin state is repaired by filling the depressed part or supplementing water and collagen which are lacked by the skin, so that the elasticity and the vitality of the skin are improved, the face is in a youthful state, and the anti-aging purpose is realized.
The beauty injection in the prior art is easy to have the phenomena of aggregation, uneven absorption and poor absorption effect, so that the problems of swelling at the injection position and poor beauty effect are caused.
Disclosure of Invention
Technical problem to be solved
Aiming at the defects of the prior art, the invention provides an anti-aging beauty injection and a preparation method thereof, and solves the problems that the beauty injection in the prior art is easy to gather, uneven in absorption and poor in absorption effect, so that the injection position is bulged and the beauty effect is poor.
(II) technical scheme
In order to achieve the purpose, the invention provides the following technical scheme: an anti-aging beauty injection and a preparation method thereof, comprising the following components by weight:
18-25 parts of physiological saline, 19-29 parts of collagen, 23-32 parts of hyaluronic acid, 7-11 parts of poly-L-lactic acid, 5-6 parts of glutathione, 2-3 parts of mannitol and 1-3 parts of vitamin.
Preferably, the vitamins include vitamin a, vitamin B, vitamin C and vitamin E.
Preferably, the vitamins comprise, by mass, 0.3-1.27 parts of vitamin A, 0.13-0.29 part of vitamin B, 0.12-0.78 part of vitamin C and 0.27-0.81 part of vitamin E.
Preferably, the vitamin B includes vitamin B3, vitamin B5, vitamin B6 and vitamin B12.
Preferably, the concentration of the physiological saline is 0.85%.
Preferably, the collagen is extracted from deep-sea fish.
Preferably, the preparation method of the anti-aging cosmetic injection comprises the following steps:
step1, taking 18-25 parts of normal saline, respectively taking 7-10 parts of collagen and 9-11 parts of hyaluronic acid, mixing with the normal saline, and magnetically stirring at low temperature for 2-5min to obtain a primary mixed solution;
step2, mixing 5-6 parts of glutathione, 2-3 parts of mannitol and 1-3 parts of vitamin with the primary mixed solution, and magnetically stirring at low temperature for 3-8min to obtain an intermediate mixed solution;
step3, mixing 6-9 parts of collagen and 7-11 parts of hyaluronic acid with the intermediate mixed solution to obtain a secondary intermediate mixed solution, and magnetically stirring at low temperature for 5-10 min;
step4, mixing 7-11 parts of poly-L-lactic acid with the secondary intermediate mixed solution, and magnetically stirring at low temperature for 10-20min to obtain a semi-finished mixed solution;
step5, mixing 6-9 parts of collagen and 7-10 parts of hyaluronic acid with the semi-finished product mixed solution, magnetically stirring at low temperature for 20-30min, adding medical additives, ultrafiltering, packaging with the specification of 1-2mL per bottle, and storing under sterile, low temperature and dark conditions.
(III) advantageous effects
The invention provides an anti-aging beauty injection and a preparation method thereof, and the injection has the following beneficial effects:
the medical injection beauty treatment material collagen and hyaluronic acid are added into the normal saline to achieve the filling effect, the normal saline is not added usually, the partial short-time body fluid secretion of cells is insufficient, the problems of slow recovery and poor absorption effect are caused, and the problem can be effectively improved by adding the normal saline; the poly-L-lactic acid has the main function of stimulating the organism to autonomously produce collagen, thereby achieving the effects of enhancing the font metabolism, beautifying the skin and resisting aging; simultaneously, the glutathione is matched, so that various enzymes can be activated, the metabolism of sugar, fat and protein is promoted, the metabolic process of cells is influenced, the absorption of the cells is promoted, and the cosmetic effect is improved; in addition, mannitol can improve the osmotic pressure of blood plasma, vitamins can improve the activity of cells, and stimulate the cells to absorb injection from multiple aspects, so that the aims of avoiding aggregation, uneven absorption and poor absorption effect are achieved, and the problems of swelling at an injection position and poor beautifying effect caused by the phenomena of aggregation, uneven absorption and poor absorption effect easily occurring in the beautifying injection in the prior art are solved.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The invention provides a technical scheme that: an anti-aging beauty injection and a preparation method thereof, comprising the following components by weight:
18-25 parts of physiological saline, 19-29 parts of collagen, 23-32 parts of hyaluronic acid, 7-11 parts of poly-L-lactic acid, 5-6 parts of glutathione, 2-3 parts of mannitol and 1-3 parts of vitamin.
As a technical optimization scheme of the invention, the vitamins comprise vitamin A, vitamin B, vitamin C and vitamin E.
As a technical optimization scheme of the invention, the vitamins comprise, by mass, 0.3-1.27 parts of vitamin A, 0.13-0.29 part of vitamin B, 0.12-0.78 part of vitamin C and 0.27-0.81 part of vitamin E.
As a technical optimization scheme of the invention, the vitamin B comprises vitamin B3, vitamin B5, vitamin B6 and vitamin B12.
As a technical optimization scheme of the invention, the concentration of the physiological saline is 0.85%.
As a technical optimization scheme of the invention, the collagen is extracted from deep-sea fish.
As a technical optimization scheme of the invention, the preparation method of the anti-aging beauty injection comprises the following steps:
step1, taking 18-25 parts of normal saline, respectively taking 7-10 parts of collagen and 9-11 parts of hyaluronic acid, mixing with the normal saline, and magnetically stirring at low temperature for 2-5min to obtain a primary mixed solution;
step2, mixing 5-6 parts of glutathione, 2-3 parts of mannitol and 1-3 parts of vitamin with the primary mixed solution, and magnetically stirring at low temperature for 3-8min to obtain an intermediate mixed solution;
step3, mixing 6-9 parts of collagen and 7-11 parts of hyaluronic acid with the intermediate mixed solution to obtain a secondary intermediate mixed solution, and magnetically stirring at low temperature for 5-10 min;
step4, mixing 7-11 parts of poly-L-lactic acid with the secondary intermediate mixed solution, and magnetically stirring at low temperature for 10-20min to obtain a semi-finished mixed solution;
step5, mixing 6-9 parts of collagen and 7-10 parts of hyaluronic acid with the semi-finished product mixed solution, magnetically stirring at low temperature for 20-30min, adding medical additives, ultrafiltering, packaging with the specification of 1-2mL per bottle, and storing under sterile, low temperature and dark conditions.
The working principle is as follows: the filling effect is achieved by adding collagen and hyaluronic acid, so that the problems of slow recovery and poor absorption effect are caused by insufficient body fluid generated locally in cells in a short time due to the fact that normal saline is not added generally, and the problems can be effectively solved by adding the normal saline; the poly-L-lactic acid has the main function of stimulating the organism to autonomously produce collagen, thereby achieving the effects of enhancing the font metabolism, beautifying the skin and resisting aging; simultaneously, the glutathione is matched, so that various enzymes can be activated, the metabolism of sugar, fat and protein is promoted, the metabolic process of cells is influenced, the absorption of the cells is promoted, and the cosmetic effect is improved; in addition, mannitol can improve the osmotic pressure of blood plasma, vitamins can improve the activity of cells, and cells are stimulated to absorb injection from multiple aspects, so that the aims of avoiding aggregation, uneven absorption and poor absorption effect are fulfilled.
In conclusion, the invention solves the problems that the beauty injection liquid in the prior art is easy to generate the phenomena of aggregation, uneven absorption and poor absorption effect, and the injection position bulges and the beauty effect is poor by adding the medical injection beauty materials of collagen and hyaluronic acid into the normal saline.
It is noted that, herein, relational terms such as first and second, and the like may be used solely to distinguish one entity or action from another entity or action without necessarily requiring or implying any actual such relationship or order between such entities or actions. Also, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.

Claims (7)

1. An anti-aging beauty injection is characterized in that: the composition comprises the following components in parts by mass:
18-25 parts of physiological saline, 19-29 parts of collagen, 23-32 parts of hyaluronic acid, 7-11 parts of poly-L-lactic acid, 5-6 parts of glutathione, 2-3 parts of mannitol and 1-3 parts of vitamin.
2. The cosmetic injection with anti-aging effect according to claim 1, wherein: the vitamins include vitamin A, vitamin B, vitamin C and vitamin E.
3. The cosmetic injection with anti-aging effect according to claim 2, wherein: the vitamin comprises, by mass, 0.3-1.27 parts of vitamin A, 0.13-0.29 part of vitamin B, 0.12-0.78 part of vitamin C and 0.27-0.81 part of vitamin E.
4. The cosmetic injection with anti-aging effect according to claim 3, wherein: the vitamin B comprises vitamin B3, vitamin B5, vitamin B6 and vitamin B12.
5. The cosmetic injection with anti-aging effect according to claim 1, wherein: the concentration of the physiological saline is 0.85%.
6. The cosmetic injection with anti-aging effect according to claim 1, wherein: the collagen is extracted from deep-sea fish.
7. The method for preparing the anti-aging cosmetic injection according to claim 6, wherein the injection comprises the following components: the method comprises the following steps:
step1, taking 18-25 parts of normal saline, respectively taking 7-10 parts of collagen and 9-11 parts of hyaluronic acid, mixing with the normal saline, and magnetically stirring at low temperature for 2-5min to obtain a primary mixed solution;
step2, mixing 5-6 parts of glutathione, 2-3 parts of mannitol and 1-3 parts of vitamin with the primary mixed solution, and magnetically stirring at low temperature for 3-8min to obtain an intermediate mixed solution;
step3, mixing 6-9 parts of collagen and 7-11 parts of hyaluronic acid with the intermediate mixed solution to obtain a secondary intermediate mixed solution, and magnetically stirring at low temperature for 5-10 min;
step4, mixing 7-11 parts of poly-L-lactic acid with the secondary intermediate mixed solution, and magnetically stirring at low temperature for 10-20min to obtain a semi-finished mixed solution;
step5, mixing 6-9 parts of collagen and 7-10 parts of hyaluronic acid with the semi-finished product mixed solution, magnetically stirring at low temperature for 20-30min, adding medical additives, ultrafiltering, packaging with the specification of 1-2mL per bottle, and storing under sterile, low temperature and dark conditions.
CN202111010494.8A 2021-08-31 2021-08-31 Anti-aging beauty injection and preparation method thereof Withdrawn CN113663059A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111010494.8A CN113663059A (en) 2021-08-31 2021-08-31 Anti-aging beauty injection and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111010494.8A CN113663059A (en) 2021-08-31 2021-08-31 Anti-aging beauty injection and preparation method thereof

Publications (1)

Publication Number Publication Date
CN113663059A true CN113663059A (en) 2021-11-19

Family

ID=78547498

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111010494.8A Withdrawn CN113663059A (en) 2021-08-31 2021-08-31 Anti-aging beauty injection and preparation method thereof

Country Status (1)

Country Link
CN (1) CN113663059A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114432203A (en) * 2022-02-23 2022-05-06 张慧姊 Restoration formula for restoring and nourishing skin firmness for injection
CN114470329A (en) * 2022-03-11 2022-05-13 上海医妃医药科技有限公司 Human albumin dermal filler
CN114533856A (en) * 2022-02-24 2022-05-27 浙江天妍生物科技有限公司 Bioactive material injection for improving skin quality and preparation method and product thereof
CN114632056A (en) * 2022-03-31 2022-06-17 苏州芳华美容医院有限公司 Compound nutrient solution for facial anti-aging
CN115089542A (en) * 2022-06-07 2022-09-23 阿谷巴(杭州)生物科技发展有限公司 Skin anti-aging repair composition containing umbilical cord mesenchymal stem cell factor
CN115501390A (en) * 2022-10-18 2022-12-23 沈阳药科大学 Skin beautifying compound injection and preparation method thereof
CN115591024A (en) * 2022-10-09 2023-01-13 深圳市科医美医疗投资有限公司（Cn） Injection for repairing skin wrinkles and preparation method thereof

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114432203A (en) * 2022-02-23 2022-05-06 张慧姊 Restoration formula for restoring and nourishing skin firmness for injection
CN114533856A (en) * 2022-02-24 2022-05-27 浙江天妍生物科技有限公司 Bioactive material injection for improving skin quality and preparation method and product thereof
CN114470329A (en) * 2022-03-11 2022-05-13 上海医妃医药科技有限公司 Human albumin dermal filler
CN114632056A (en) * 2022-03-31 2022-06-17 苏州芳华美容医院有限公司 Compound nutrient solution for facial anti-aging
CN115089542A (en) * 2022-06-07 2022-09-23 阿谷巴(杭州)生物科技发展有限公司 Skin anti-aging repair composition containing umbilical cord mesenchymal stem cell factor
CN115591024A (en) * 2022-10-09 2023-01-13 深圳市科医美医疗投资有限公司（Cn） Injection for repairing skin wrinkles and preparation method thereof
CN115501390A (en) * 2022-10-18 2022-12-23 沈阳药科大学 Skin beautifying compound injection and preparation method thereof

Similar Documents

Publication Publication Date Title
CN113663059A (en) Anti-aging beauty injection and preparation method thereof
CN109170469A (en) A kind of Isin glue collagen peptide solid beverage and preparation method thereof
CN102406664B (en) Method for producing deer skin collagen
CN104194989A (en) Nourishing wine and preparation method thereof
CN103923789A (en) Health care medicinal liquor
CN115428877A (en) Beautifying and face nourishing sodium hyaluronate composite beverage and preparation method thereof
CN103432059B (en) Loranthus kaempferi paste egg white mask
CN101433668A (en) Prescription of wine for beauty treatment and face nursing and production method
CN101537081B (en) Matsutake health-care medicinal liquor with anticancer function and human body immunizing power enhancement function
CN103251548A (en) Selenium-enriched watermelon and egg white mask cream
CN104397183A (en) Preparation method of hyaluronic acid milk
CN107794207A (en) A kind of fruit vinegar of beautifying face and moistering lotion and preparation method thereof
CN101711565A (en) Donkey-hide glue yam powder
CN107496194A (en) A kind of surfactant and preparation method thereof
CN111773379A (en) Injectable whitening wrinkle-removing preparation, preparation method and application thereof
CN103704428A (en) Ginkgo health tea and preparation method thereof
CN109182021A (en) A kind of lycium ruthenicum wine
CN103040943A (en) Chinese medicinal liniment for treating premature graying of youngsters
CN106038375A (en) Quantum cell proliferation medical skin shining facial mask and preparation method
CN111235201A (en) Deer bone peptide and extraction method thereof
CN101843838A (en) Health-care medicated wine and preparation method thereof
CN104293598A (en) Ginseng and wolfberry wine
CN106929365A (en) A kind of dendrobium candidum health liquor
CN108450956A (en) A kind of beautifying nourishing liquid
CN103653105A (en) Method for preparing health-care tremella beverage

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20211119